Show simple item record

dc.contributor.authorHebbar, Meghnaa
dc.contributor.authorKhalil, Halimah
dc.contributor.authorZia, Nawal
dc.contributor.authorSheikh, Jameela
dc.contributor.authorMelson, Eka
dc.contributor.authorDavitadze, Meri
dc.contributor.authorGleeson, Helena
dc.contributor.authorLathia, Tejal
dc.contributor.authorSelvan, Chitra
dc.contributor.authorKempegowda, Punith
dc.date.accessioned2023-10-11T10:15:07Z
dc.date.available2023-10-11T10:15:07Z
dc.date.issued2023-09-27
dc.identifier.citationHebbar M, Khalil H, Zia N, Sheikh J, Melson E, Davitadze M, Gleeson H, Lathia T, Selvan C, Kempegowda P. Improving emotional and psychosexual well-being screening in women living with polycystic ovary syndrome: experiences from the United Kingdom and India. Endocr Connect. 2023 Sep 27;12(11):e230179. doi: 10.1530/EC-23-0179.en_US
dc.identifier.issn2049-3614
dc.identifier.doi10.1530/EC-23-0179
dc.identifier.pmid37646639
dc.identifier.urihttp://hdl.handle.net/20.500.14200/2457
dc.description.abstractWith increasing evidence of emotional well-being disorders associated with polycystic ovary syndrome (PCOS), effective screening processes are of utmost importance. We studied the impact of using questionnaires to screen for emotional and psychosexual well-being across different models of care for PCOS. We analysed the data from the surveys to assess the difference in the prevalence of emotional and psychosexual ill-being across ethnicity and region. In this prospective cohort study, we invited all women attending consultations for PCOS in Birmingham, UK, and Bengaluru and Navi Mumbai, India. Those who consented to participate in the study were invited to complete a pre-clinic survey about socio-demographic data, Hospital Anxiety and Depression Scale (HADS), Body Image Concern Inventory (BICI), Beliefs about Obese Person scale (BAOP), and Female Sexual Function Index score (FSFI) and a post-clinic survey on clinic experience, lifestyle advice, and specialist referral. A total of 115 women were included in this study. The rate of questionnaire completion was 98.3% (113/115), 97.4% (112/115), 93.04% (107/115), and 84.3% (97/115) for HADS, BICI, BAOP, and FSFI, respectively. In the post-clinic survey, 28.8% reported they were screened for anxiety, 27.1% for depression, and 45.8% for body image concerns. The prevalence of anxiety, depression, and body dysmorphic disorder through pre-clinic survey was 56.5% (50.0% UK vs 59.5% India, P = 0.483), 16.5% (13.9% UK vs 17.7% India, P = 0.529), and 29.6% (36.1% UK vs 26.6% India, P = 0.208), respectively. Surveys with validated questionnaires can improve screening for emotional and psychosexual well-being associated with PCOS which may be missed by ad hoc screening during consultations.en_US
dc.language.isoenen_US
dc.publisherBioScientificaen_US
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/journals/2122/en_US
dc.relation.urlhttp://www.endocrineconnections.com/en_US
dc.subjectGynaecologyen_US
dc.subjectEndocrinologyen_US
dc.titleImproving emotional and psychosexual well-being screening in women living with polycystic ovary syndrome: experiences from the United Kingdom and Indiaen_US
dc.typeArticle
dc.source.journaltitleEndocrine Connections
dc.source.volume12
dc.source.issue11
dc.source.countryEngland
rioxxterms.versionNAen_US
dc.contributor.trustauthorGleeson, Helena
dc.contributor.trustauthorKempegowda, Punith
dc.contributor.departmentEndocrinologyen_US
dc.contributor.departmentDiabetes
dc.contributor.roleMedical and Dentalen_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record